Agile_Logo-color on white.jpg
Agile Therapeutics Acknowledges New Government Guidance Reinforcing Requirement to Cover Contraceptives that a Woman and Her Heathcare Provider Determine are Medically Appropriate at No Cost
January 12, 2022 17:29 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- On January 10, 2022, the tri-agencies, Department of Labor (DOL), Health and Human Services (HHS) and Treasury issued new guidance that supports...
Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results
January 09, 2022 14:00 ET | Emergent BioSolutions
Expects a re-baseline of operations with stable revenue contributions from core products and services business in 2022, guiding to total revenues of $1.45 billion at the midpoint and Adjusted EBITDA...
Agile_Logo-color on white.jpg
Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022 08:03 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will...
Emergent BioSolutions to Participate in Investor Conferences
January 03, 2022 06:30 ET | Emergent BioSolutions
GAITHERSBURG, Md., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...